Journal Article

Evaluation design of the patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard (InAdvance): a randomised controlled trial

López, Maria-Eugenia Gas, Doñate-Martínez, Ascensión, Eze, Jude, Camacho, Mariana, Linklater, Gordon, Yang-Huang, Junwen, Gama, Ana, Garcés, Jorge, Raat, Hein, Romero, Raquel Valcarcel, Hines, Frances, Reppou, Sofia, Bamidis, Panagiotis D., Fernandes, Adriano, Campos, Maria Soledad Gimenez

2022

Overview

Background Palliative care aims to contribute to pain relief, improvement with regard to symptoms and enhancement of health-related quality of life (HRQoL) of patients with chronic conditions. Most of the palliative care protocols, programmes and units are predominantly focused on patients with cancer and their specific needs. Patients with non-cancer chronic conditions may also have significantly impaired HRQoL and poor survival, but do not yet receive appropriate and holistic care. The traditional focus of palliative care has been at the end-of-life stages instead of the relatively early phases of serious chronic conditions. The ‘Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard’ (InAdvance) project implements and evaluates early palliative care in the daily clinical routine addressing patients with complex chronic conditions in the evolution towards advanced stages. The objective of the current study is to evaluate the acceptability, feasibility, effectiveness and cost-effectiveness of this novel model of palliative care in the relatively early phases in patients with chronic conditions. Methods In this study, a single blind randomised controlled trial design will be employed. A total of 320 participants (80 in each study site and 4 sites in total) will be randomised on a 1:1 basis to the Palliative Care Needs Assessment (PCNA) arm or the Care-as-Usual arm. This study includes a formative evaluation approach as well as a cost-effectiveness analysis with a within-trial horizon. Study outcomes will be assessed at baseline, 6 weeks, 6 months, 12 months and 18 months after the implementation of the interventions. Study outcomes include HRQoL, intensity of symptoms, functional status, emotional distress, caregiving burden, perceived quality of care, adherence to treatment, feasibility, acceptability, and appropriateness of the intervention, intervention costs, other healthcare costs and informal care costs. Discussion The InAdvance project will evaluate the effect of the implementation of the PCNA intervention on the target population in terms of effectiveness and cost-effectiveness in four European settings. The evidence of the project will provide step-wise guidance to contribute an increased evidence base for policy recommendations and clinical guidelines, in an effort to augment the supportive ecosystem for palliative care. Trial registration ISRCTN, ISRCTN24825698 . Registered 17/12/2020.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Aged patients / Aging / Care and treatment / Caregivers / Chronic illnesses / Chronic obstructive pulmonary disease / Clinical practice guidelines / Complex chronic conditions / Cost analysis / Cost control / Cost-Benefit Analysis / Early identification / Ecosystem / Ecosystems / Evaluation / Formative evaluation / Geriatrics / Geriatrics/Gerontology / Health care / Humans / Intervention / Medicine / Medicine & Public Health / Methods / Morbidity / Needs assessment / Neoplasms / Older people / Older persons / Palliation / Palliative care / Palliative Care - methods / Palliative treatment / Patient care planning / Patient-centered care / Patient-centred care / Patients / Proliferating Cell Nuclear Antigen / Quality of Life / Rehabilitation / Single-Blind Method / Study Protocol